First Worldwide Proficiency Study on Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Complex Strains
de Beer, J.L., Kremerb, K., Ködmön, C., Supplyd, P., van Soolingen, D., the Global Network for the Molecular Surveillance of Tuberculosis, 2009
Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex
De Beer, J.L., Ködmon, C., Van Ingen, J., Supply, P., Van Soolingen, D., Jamieson, F.B., Bidovec-Stojkovic, U., Brown, T., Cirillo, D.M., Cruz, L., Mira, A., Dou, H.-Y., Fauville-Dufaux, M., Fitzgibbon, M.M., García De Viedma, D., Groenheit, R., Haanperä-Heikkinen, M., Indra, A., Kam, K.M., Kramer, R., Jiang, G.-L., Niemann, S., Obrovac, M., Rasmussen, E.M., Refrégier, G., Realpe, T., Samper, S., Sharma, M.K., Sougakoff, W., Stakenas, P., Stavrum, R., Trenkler, J., WaDa T., Siame, K.K., Tafaj, S., Cowan, L., Sng, L.-H., Seagar, A.-L., Basu, I., Rastogi, N., Ferro, B.E., de Matos, F., Kipnis, A., van Soolingen, D., Supply, P.
External quality assessment for tuberculosis diagnosis and drug resistance in the European union: A five year multicentre implementation study
Nikolayevskyy, V., Hillemann, D., Richter, E., Ahmed, N., Van Der Werf, M.J., Kodmon, C., Drobniewski, F., Ruesch-Gerdes, S.
ERLN-TB expert opinion on the use of the rapid molecular assays for the diagnosis of tuberculosis and detection of drug resistance
According to this report, the use of rapid molecular assays has diagnostic value in tuberculosis (TB) identification and detection of drug resistance, although there is not enough evidence to recommend these tools in all populations and situations and they should not replace standard diagnostic methods.
Mathematical modelling of programmatic screening strategies for latent tuberculosis infection in countries with low tuberculosis incidence
Elimination of tuberculosis (TB) requires the management of latent tuberculosis infection (LTBI) in key populations. Thus, people with LTBI need to be diagnosed and treated with appropriate regimens. It is unknown how different screening and treatment strategies of key populations affect TB transmission and progress toward elimination.
Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.
Social determinants and risk factors in tuberculosis surveillance in the EU/EEA
The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
Systematic review on the prevention and control of blood-borne viruses in prison settings
The objective of this report was to systematically review data on prevention and control of BBVs in prison settings, with a focus on the countries of the European Union (EU) and the European Economic Area (EEA).
Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management
This report is part of a series of technical documents describing the collection, synthesis and appraisal of the available information on specific measures for the prevention, identification and treatment of LTBI, analysed from the perspective of national TB-control programmes.
Healthcare system factors influencing treatment results of patients with multidrug-resistant tuberculosis
Qualitative research was carried out in four EU countries to try to identify the factors of a healthcare system that are key to achieving good treatment results for patients with multidrug-resistant tuberculosis.